Search

Cassava mosaic disease (CMD), caused by cassava mosaic geminiviruses (CMGs), is a major constraint to the cassava crop in Africa and southeastern Asia. Here, we investigated the ability of acibenzolar-S-methyl (ASM), a functional analog of salicylic acid (SA), to trigger systemic acquired resistance (SAR) against two CMGs, namely African cassava mosaic virus (ACMV) and East African cassava mosaic Cameroon virus (EACMCV) in Nicotiana benthamiana. ASM treatment delayed the time to first viral symptoms appearance, reduced virus infection rate, and attenuated symptoms. Furthermore, ASM caused an enhanced recovery from symptoms of both viruses and inhibited plant death observed in N. benthamiana plants infected by EACMCV. This study further showed that ASM induced resistance to the whitefly Bemisia tabaci (Gennadius), the vector of CMGs, in cassava. Notably, we observed that ASM treatment affected adult whitefly feeding preference and oviposition in cassava under both choice and no-choice conditions. A significant reduction in whitefly adult, egg, and nymph populations was observed irrespective of ASM treatment. The results of this study show that ASM has the potential to control both CMGs and their whitefly vector which is an important first step toward managing whitefly and cassava viruses. • Acibenzolar-S-methyl (ASM) induces resistance against cassava mosaic geminiviruses and whiteflies. • Resistance induction by ASM resulted in recovery of Nicotiana benthamiana from viral symptoms. • ASM significantly reduced whitefly adult, egg, and nymph populations on cassava. • ASM could be exploited in improving virus and whitefly vector resistance. [ABSTRACT FROM AUTHOR]